Aprea Therapeutics Files for $86 Million IPO

Aprea Therapeutics Files for $86 Million IPO

Source: 
CP Wire
snippet: 

On 9/6/19 Aprea Therapeutics https://www.aprea.com filed the paperwork for its IPO. The company anticipates raising up to $86 million. Aprea has facilities in Boston, MA and Stockholm, Sweden. The company will trade NDADAQ under the symbol, "APRE."